New research has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body's immune response in advanced ovarian cancer. The findings offer new ...

This year is expected to see about 12,730 ovarian cancer-related deaths and some 20,890 diagnoses in the U.S. alone, according to Merck.

The studies also pointed to the polar lipid PC (36:1) as a contributor to NK cell dysfunction in ovarian cancer, with data suggesting “… that uptake of PC (36:1), and likely other certain ...

Novel drug combinations that improve survival outcomes, questions about treatment sequence, and encouraging results in chemo-resistant disease are highlights in ovarian cancer from ASCO 2025.

IMUNON, Inc. has announced significant progress in cancer treatment, specifically with its lead candidate IMNN-001, which has shown promising results in the Phase 2 OVATION 2 study for advanced ...

In the randomized, double-blind KEYNOTE-B96 trial (ClinicalTrials.gov Identifier: NCT05116189), study participants with platinum-resistant recurrent ovarian cancer (N=643) were randomly assigned ...

There is no screening for ovarian cancer, and its symptoms—such as GI issues or back pain—are often misdiagnosed. Funds raised at events like Runway for Hope go toward research.

Key Takeaways Zentalis Pharmaceuticals progresses with azenosertib in the DENALI trial for Cyclin E1-positive platinum-resistant ovarian cancer, aiming for FDA approval by 2026. Part 2a of the trial ...

Women-founded company partners with CU Anschutz to develop ovarian cancer test Inside the Reproductive Sciences Lab at the University of Colorado Anschutz Medical Campus in Aurora, researchers are ...

The retrospective cohort study included all patients diagnosed with ovarian cancer between 2004 and 2020 in the US National Cancer Database (NCDB). Each patient’s CA-125 level was classified as ...

Rinatabart sesutecan (Rina-S) is an antibody-drug conjugate that targets folate receptor-alpha (FRα) and delivers a TOP1 inhibitor directly to cancer cells, according to a press release, which went on ...